Callan Family Office’s MasTec MTZ Stock Holding History

Callan Family Office’s Portfolio MTZ Stock Details MTZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$345K	Buy	829 +115	+16%	+$44K	0.01%	948
2026 Q1	$230K	Buy	+714	New	+$193K	0.01%	1018

Other funds holding MTZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Peconic Partners New York $8.04B AUM 107.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HCC

Hill City Capital Boston, Massachusetts $4.28B AUM 80.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Callan Family Office's MTZ Position: Q2 2026 in Review

Callan Family Office increased its MasTec (MTZ) stake by 16% in Q2 2026, buying an estimated $44K and bringing the position to 829 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #948.

Callan Family Office first reported a position in MTZ in Q1 2026 and has held it in 2 quarters since. 910 funds tracked by Wall St. Rank hold MTZ as of Q2 2026.

Callan Family Office held 829 shares of MasTec worth $345K as of Q2 2026.
Callan Family Office bought 115 MasTec shares in Q2 2026, an estimated $44K.
MasTec made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #948 holding.
Callan Family Office first reported a position in MasTec in Q1 2026 and has held it in 2 quarters since.
910 funds tracked by Wall St. Rank held MasTec as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.